Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (100.0%)Liver Cell Transplant for Phenylketonuria
Phase 1
Terminated
- Conditions
- Phenylketonuria
- Interventions
- Radiation: Preparative Radiation TherapyProcedure: Hepatocyte TransplantDrug: ImmunosuppressionOther: Liver EvaluationBehavioral: Neuro-psychological AssessmentDiagnostic Test: Whole body Phe oxidation testingProcedure: Liver Biopsy
- First Posted Date
- 2011-11-04
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- Ira Fox
- Target Recruit Count
- 1
- Registration Number
- NCT01465100
- Locations
- 🇺🇸
UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Hepatocyte Transplantation for Liver Based Metabolic Disorders
Phase 1
Terminated
- Conditions
- Metabolic Diseases
- Interventions
- Drug: human hepatocyte transplantationRadiation: Preparative Radiation Therapy
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Ira Fox
- Target Recruit Count
- 5
- Registration Number
- NCT01345578
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
Hepatocyte Transplantation for Acute Decompensated Liver Failure
Phase 1
Withdrawn
- Conditions
- Liver Failure Acute
- Interventions
- Drug: human hepatocytes
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- Ira Fox
- Registration Number
- NCT01345565
- Locations
- 🇺🇸
Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania, United States
News
No news found